SCIENCE GROUP PLC

Transaction in Own Shares • Oct 30, 2025

National Storage Mechanism | Additional information

RNS Number : 3847F

Science Group PLC

30 October 2025

30 October 2025

Science Group plc

(the "Company" or "Science Group")

Transaction in own shares

Science Group plc (AIM:SAG) announces that, on 29 October 2025, it purchased 17,500 of its 1 pence ordinary shares at an average price of 551.25 pence per share. The highest price paid per share was 551.25 pence and the lowest price paid per share was 551.25 pence. The Company purchased these shares through Panmure Liberum Limited.

The number of shares purchased represented 0.04% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 44,128,142.  Science Group holds 2,057,732 shares in treasury.

The figure of 44,128,142 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Panmure Liberum Limited on behalf of the Company as part of the buyback programme.

Number of shares purchased	Transaction price (per share)	Time of transaction	Execution venue
17500	551.25	13:05:47	AIMX

- Ends -

For further information:

Science Group plc
Sarah Cole, Company Secretary	Tel: +44 (0) 1223 875 200
Panmure Liberum Limited (Nomad and Broker)
Nicholas How, Max Jones, John More	Tel: +44 (0) 20 3100 2000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSPKCBPABDDOKB